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Abstract
Introduction and hypothesis Pelvic organ prolapse (POP)
and other disorders, such as varicose veins and joint
hypermobility, have been associated with changes in
collagen strength and metabolism. We hypothesized that
these various disorders were more prevalent in both POP
patients and their family members.
Methods In this study, the prevalence of various collagen-
associated disorders, including POP, was compared between
POP patients (n=110) and control patients (n=100) and
their first and second degree family members.
Results POP patients reported a higher prevalence of
varicose veins, joint hypermobility and rectal prolapse and
were more likely to have family members with POP as
compared to the control group (p<0.01). In contrast, the
family members of the POP group did not report a higher
prevalence of collagen-associated disorders compared to the
family members of the control group (p=0.82).
Conclusions POP and other collagen-associated disorders
may have a common aetiology, originating at the molecular
level of the collagens.
Keywords Pelvic organ prolapse.Collagen.Heredity.
Varicose veins.Rectal prolapse.Joint hypermobility
Abbreviations
POP Pelvic organ prolapse
EDS Ehlers–Danlos syndrome
AAA Abdominal aorta aneurysm
POP-Q Pelvic organ prolapse quantification
POF Premature ovarian failure
BMI Body mass index
Introduction
Pelvic organ prolapse (POP) is a common condition among
adult vaginally parous women of all ages, with reported
prevalence numbers up to 37% [1]. It has previously been
stated that an alteration in collagen metabolism is relevant
in the aetiology of POP. Jackson et al. have formulated this
finding in 1996, and it has been supported since [2, 3].
Collagen is a fibrous protein and the main component of
connective tissue. It provides tensile strength to skin,
tendons and bones [2]. In the 1930s, the first evidence for
a regular structure of collagen molecules was found, and so
far, more than 20 subtypes have been identified. Types I, III
and V are the principal components to provide strength to
soft tissues. Collagen type I is non-elastic and confers great
resistance to tensile forces, whereas collagen type III has
elastic properties and is prevailing in more flexible tissues.
Both type I and III collagens are present in granulation
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DOI 10.1007/s00192-011-1532-ytissue during wound repair [3]. Type V collagen is a
quantitatively minor fibrillar collagen, but it is widely
distributed in a variety of tissues [4]. An increase in
collagen type III and V is associated with a decrease in
mechanical strength of connective tissue due to decreased
fibre size. It is generally agreed that a higher I to III ratio in
tissues is indicative of greater strength, whereas a lower
ratio may result in tissue laxity [3]. Collagen-associated
disorders may arise from genetic defects, which can affect
any step in the normal collagen production.
The most eminent inherited collagen-associated disorder
is the Ehlers–Danlos syndrome (EDS). This syndrome
consists of a heterogeneous group of clinical features
caused by underlying defects in the collagen type I, III
and V gene as well as defects in proteins important for the
post-translational modifications and processing of these
collagens [5]. It is known that female patients with EDS
have a higher risk of developing POP [6]. Besides, both
male and female patients with one of the different subtypes
of EDS reported a higher prevalence of joint hypermobility;
arterial rupture; rupture of diaphragm; atrophic scarring;
varicose veins; cardiac valvular disease, such as cardiac
valve prolapse; rectal prolapse and inguinal, umbilical or
other hernias [5]. Other investigators have focused on these
different diseases in the general population and their
relation to collagen. They found changes in collagen
quantity or composition of the different collagen subtypes
in for example patients with POP [2, 3], inguinal hernia [7–
10], varicose veins [11–13], arterial aneurysm [14] and joint
hypermobility [15]. This suggests a common pathophysio-
logic pathway for both POP and the above-mentioned
disorders.
If changes in collagen are an underlying cause of all
these disorders, one would expect that they coexist in the
same patient. Moreover, if these collagen changes are based
on genetic defects, family members of these patients are
expected to be affected more often. Miedel et al. have found
that a history of conditions suggestive of deficient
connective tissues, such as varicose veins, hernia and
hemorrhoid, was significantly associated with symptomatic
P O Pi nt h e s ew o m e n[ 16]. Furthermore, it has been
reported that patients with abdominal aorta aneurysm are
at higher risk for inguinal hernia repair and abdominal wall
hernias [17, 18] and that POP patients more often report
joint laxity [19–21]. Until now however, it is not known
whether the incidence of these collagen-associated disor-
ders is higher in families of women with POP, which would
be expected in case of inheritable collagen disorders.
The aim of this study was to assess the association
between POP and other collagen-associated disorders. We
hypothesized that POP patients more often have concom-
itant collagen-associated disorders as compared to controls.
Furthermore, we hypothesized that these various disorders,
including POP, are more prevalent in the genetically related
first and second degree family members of POP patients
than in family members of controls.
Materials and methods
An observational cohort study was conducted among
consecutive gynaecological patients between January 2007
and August 2010 at the Department of Obstetrics and
Gynaecology of the Radboud University Nijmegen Medical
Centre, the Netherlands. During the study period, all these
patients underwent gynaecological examination and they
completed a questionnaire on parity and hormonal status,
smoking habits, weight, height and medical and surgical
history. Besides, information on POP in their first and
second degree female family members was obtained.
Additionally, detailed questions on the presence of con-
ditions suggestive of deficient connective tissue in the
patients and their family members were completed by the
patients presenting at our department between January 2009
and August 2010.
Data were also used from women previously included in
another study protocol, in which female family members
were elaborately interviewed on their medical history,
including specific questions on gynaecological history. Data
were collected either by telephone interview or by written
questionnaire. The primary outcome of that study was the
prevalence of premature ovarian failure (POF, i.e. amenor-
rhea before age of 40 years) in families with a patient with
Fragile X syndrome [22]. These women did not undergo
gynaecological examination at our department.
All our gynaecological patients as well as the first female
family member of the families that were interviewed for the
POF study are subsequently referred to as index cases.
Index cases were considered a “POP index case” if they
had clinical signs of POP on gynaecological examination
(POP-Q stage two or higher) [23] and/or had undergone
POP surgery in the past. Women who were not examined at
our department, but who had undergone POP operation(s)
previously or were diagnosed with POP by a medical
professional, were also included in this group.
Women were classified as being a “control index case” if
they had no signs and symptoms of POP, at the time of the
study or in the past. Female family members were
considered as having POP if they had undergone POP
operation(s) previously or were diagnosed with POP by a
medical professional.
Index cases and first and second degree family members,
both male and female, were considered as having a
collagen-associated disorder if they had a history of one
or more of the following diseases: arterial aneurysm,
inguinal hernia, cardiac valve prolapse, varicose veins,
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hernia), umbilical hernia, joint hypermobility and rectal
prolapse. Joint hypermobility was considered present if a
person responded positive on the question if they had ever
had a luxation or sprain of a joint. Subsequently, these eight
disorders are referred to as the collagen-associated disor-
ders. Two disorders were assessed separately with one
being fascia wound dehiscence and the other diaphragmatic
hernia. Fascia wound dehiscence was mentioned separately
because to develop this disorder, one had to have undergone
abdominal surgery and furthermore, fascia wound dehis-
cence could be the result of operation technique. Diaphrag-
matic hernia was assessed separately because this might be
the result of an embryologic development disorder which
does not necessarily reflect a collagen-associated disorder
as such and moreover, this disorder might be present
without the patient knowing.
Both POP and control index cases had to fulfill two
inclusion criteria: because POP in general develops later in
life, all index cases had to be 50 years or older at the time
of participation. Since vaginal delivery is regarded as the
major risk factor for the development of POP, all index
cases had to be vaginally parous as well. Exclusion criteria
for all index cases were the presence of genetic diseases
with a known increased risk of POP, such as Ehlers–Danlos
syndrome, and furthermore, inadequate comprehension of
the Dutch language.
The study protocol was approved by the institutional
research ethics committee under number CMO 2007/043
and informed consent was obtained from all participants.
Statistical methods
The Kruskal–Wallis test was used to test differences
between the two groups for statistical significance in case
of continuous variables and the Fisher’s exact test was used
in case of 2×2 tables. Multivariate logistic regression was
used to study possible confounders in the relation between
presence of collagen-associated disorders and POP, using
the index cases only. The dependent variable was presence
of collagen-associated disorders. Confounders of interest in
this study were: parity, BMI, smoking, menopause and
pulmonary disease. Analyses were performed using SPSS
16.0 (Chicago, IL, USA) for Windows. p values below .05
were considered statistical significant.
Results
A total of 237 women met the inclusion criteria for index
case. Of these, 165 were included during routine clinical
practise and 72 were from the study on POF. Twenty-seven
medical records did not include information on collagen-
associated disorders in either the patient or her family
members, neither was there information available on the
prevalence of POP in female family members and we were
not able to obtain this information otherwise. These women
were therefore excluded from analyses. Thus, 110 POP
index cases and 100 control index cases were included in
this study.
Figure 1 shows a flowchart of the study. The POP and
control index cases are subdivided according to inclusion
during routine clinical practise and inclusion from the POF
study.
Table 1 shows the number of families of POP and control
index cases by their number of siblings and their number of
children. POP index cases had in 78% of the cases
“average” sized families with 54 women having two
children and 32 women having three children ((54+32)/
110=78%), compared to 67% in control index cases ((38+
29)/100). Control index cases more often had larger
families (≥5 children) compared to POP index cases (17%
(17/100) and 5% (6/110), respectively). On average, the
number of siblings was the same between both groups even
though 7% (8/110) of POP index cases had two siblings
compared to 17% (17/100) of control index cases.
Consequently, more POP index cases had ≥5 siblings
compared to control index cases, 45% (49/110) and 32%
(32/100), respectively.
Table 2 outlines the baseline characteristics of the index
cases as well as the number of collagen-associated disorders
in both POP and control index cases and in their first and
second degree family members. Both groups of index cases
were comparable with regard to age, BMI, menopause and
pulmonary disease. There was a statistical significant
difference between both groups regarding number of
237 index cases  
met inclusion 
 criteria 
27 index cases lost due to
missing information
110 POP index cases 100 control index cases 
routine          routine 
clinical POF-study          clinical POF-study 
practice          practice 
n = 101 n = 9      n = 37     n = 63
POP, pelvic organ prolapse. POF, premature ovarian failure 
Fig. 1 Flowchart of index cases included in the study
Int Urogynecol J (2012) 23:313–319 315children and smoking (p=0.03 and p=0.02, respectively).
Varicose veins, hypermobility and rectal prolapse were
significantly more often reported by POP index cases (p<
0.01). Regarding the presence of at least one collagen-
associated disorder, a statistical significant difference was
found between both groups (p<0.01), with collagen-
associated disorders being more prevalent in the group of
POP index cases. Using logistic regression, the relation
between POP and collagen-associated disorders was similar
after correction for parity and smoking.
Mothers of POP index cases were nearly four times more
likely to have (had) POP themselves as compared to mothers
of control index cases (p<0.01) whereas sisters of POP index
cases were nearly nine times more likely to have (had) POP
compared to sisters of control index cases (p<0.01).
A minimal larger percentage of family members of POP
index cases was affected by a collagen-associated disorder.
Nineteen percent (12/63) of POP index cases had a family
member that was affected, while this accounted for 14%
(12/84) of the control index cases. This difference was not
statistically significant (p=0.82).
Discussion
In this observational cohort study, we assessed whether the
prevalence of collagen-associated disorders was higher
among women with POP and among their first and second
degree family members compared to controls and their
families. The presence of a collagen-associated disorder,
independent of the number of reported collagen-associated
disorders, was statistically significant higher in the POP
index cases as compared to controls. Varicose veins, joint
hypermobility and rectal prolapse were each significantly
more prevalent in the POP index cases. With regard to the
families of the index cases, a higher prevalence of POP
among female family members of POP index cases was
found. With our data, we were not able to identify a
difference between both groups regarding the prevalence of
collagen-associated disorders in first and second degree
family members. To our best knowledge, no previous study
has assessed the combination of these various collagen-
associated disorders together, in relation to POP.
Our study revealed that mothers and sisters of POP index
cases were respectively nearlyfourand nine timesmorelikely
to report POP as compared to mothers and sisters of control
index cases. This is in line with findings of previous studies
that reported a higher risk of POP in women with mothers or
sisters reporting POP [24–28]. Even though the aetiology of
P O Pi sc o m p l e x ,i ti sr e c o g n i z e dt ob em u l t i f a c t o r i a li ni t s
origin with an eminent contribution of genetics. A large twin
study showed that heritability contributes significantly to the
occurrence of POP [29]. These observations support the
hypothesis that a genetic predisposition to the condition
exists and therefore we expected more collagen-associated
disorders in women with POP and their first and second
degree family members.
Prevalence of POP is significantly correlated with the
occurrence of a collagen-associated disorder. The presence
of either varicose veins, joint hypermobility or rectal
prolapse is individually correlated to the presence of POP.
The finding that a higher prevalence of varicose veins
Number of children Number of siblings
012 3 4 ≥5 Unknown Total
POP
0 – – ––––– –
1 – 3 11332 1 3
21 3 5 1 1 5 2 1 8 5 4
3 – 3 1231 9 4 3 2
4 ––– 113– 5
≥5 ––1113– 6
Total 1 9 8 16 13 49 14 110
Control
0 – – ––––– –
11 – 23– 31 1 0
2 1 2 7191 2 6 3 8
3 – 3 5511 1 4 2 9
4 – 1 1112– 6
≥5 – 1 23344 1 7
Total 2 7 17 13 14 32 15 100
Table 1 Size and structure
of families of POP and control
index cases
POP pelvic organ prolapse
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agreement with observations of Miedel et al. [16] Further-
more, we confirm the previously reported association
between self-reported joint hypermobility and POP [19–
21, 30]. The study of Hansell et al. showed that the
influence of common genes may underlie the association
between elbow mobility and POP [31]. Furthermore,
Knuuti et al. found that women with joint hypermobility
and recurrence of POP have significantly high concen-
trations of type III collagen [32]. Together with our
findings, it seems likely that a common defect affecting
collagen strength or metabolism is responsible for these two
Table 2 Characteristics and disorders of POP and control index cases and their first and second degree family members
Index cases POP total n (%) or median [range] Control total n (%) or median [range] p value
Age [years] 110 63 [51–89] 100 64 [51–95] 0.37
Children [number] 110 2 [1–11] 100 3 [1–10] 0.03
BMI [kg/m
2] 84 25 [17–41] 90 25 [19–42] 0.33
Smoking
a 65 21 (32) 83 38 (46) 0.02
Menopause
b 93 89 (96) 94 89 (95) 0.14
Pulmonary disease
c 54 7 (13) 84 9 (11) 0.09
Collagen-associated disorders
d
- AAA 59 0 (0) 84 1 (1) 1.00
- Inguinal hernia 55 0 (0) 84 0 (0) 1.00
- Cardiac valve prolapse 58 0 (0) 84 2 (2) 0.51
- Varicose veins 55 15 (27) 84 5 (6) <0.01
- Intervertebral disc displacement 53 5 (9) 84 8 (10) 1.00
- Umbilical hernia 53 3 (6) 84 2 (2) 0.38
- Joint hypermobility 63 12 (19) 82 2 (2) <0.01
- Rectal prolapse 53 13 (25) 84 0 (0) <0.01
Presence of collagen-associated disorder
b 63 31(49) 84 18(21) <0.01
Fascia wound dehiscence 53 2 (4) 84 1 (1) 0.56
Diaphragmatic hernia 52 1 (2) 84 1 (1) 1.00
First and second degree family members
Prolapse
- Mother 110 77 (70) 100 20 (20) <0.01
- Sisters 231 78 (34) 166 6 (4) <0.01
Collagen-associated disorders
d
- AAA 59 1 (2) 84 1 (1) 1.00
- Inguinal hernia 55 7 (13) 84 1 (1) 0.62
- Cardiac valve prolapse 58 0 (0) 84 2 (2) 0.23
- Varicose veins 55 5 (9) 84 8 (10) 0.53
- Intervertebral disc displacement 53 9 (17) 84 8 (10) 0.78
- Umbilical hernia 53 0 (0) 84 1 (1) 0.48
- Joint hypermobility 63 0 (0) 82 2 (2) 0.23
- Rectal prolapse 53 0 (0) 84 0 (0) 1.00
Presence of collagen-associated disorder
e 63 12 (19) 84 12 (14) 0.82
Fascia wound dehiscence 53 0 (0) 84 0 (0) 1.00
Diaphragmatic hernia 52 1 (2) 84 2 (2) 0.61
p value for difference between POP and control groups using Fisher’s Exact test except for patient characteristics for which Kruskal–Wallis test
was used
POP pelvic organ prolapse, BMI body mass index, AAA abdominal aorta aneurysm
aIncluding former smokers
bIncluding post-menopausal women using hormone replacement therapy
cIncluding asthma, chronic obstructive pulmonary disease, bronchitis and other pulmonary diseases
dMultiple diagnoses per person possible
eAt least one of the collagen-associated disorders mentioned above
Int Urogynecol J (2012) 23:313–319 317disorders. Whether this is also the case for rectal prolapse,
the third collagen-associated disorder individually more
frequent observed in POP patients, will need to be
confirmed in additional studies. From a clinical point of
view, other risk factors such as chronic constipation,
excessive straining, and age might be a major risk factor
for rectal prolapse, although the higher prevalence of rectal
prolapse in EDS patients makes a genetic susceptibility
likely as well. The underlying cause is most likely a
combination of both genetic and non-genetic risk factors.
Collagen-associated disorders in relation to POP are still
poorly understood. Until now, connective tissues have been
assessed through biochemical evaluation of the collagen
metabolism in the local tissues, and only few genetic
polymorphisms have been studied [33, 34]. The available
data on the changes in local collagen metabolism are often
conflicting. Most recent studies found a decrease in
collagen I to III ratio and a higher level of collagen type
III in both POP and other collagen-associated disorders. A
recent study by Haviarova et al., for example, reported a
lower collagen I to III ratio and significantly more collagen
type III in varicose vein walls [11]. This was, however, in
contrast with a previous report on down-regulated collagen
type III and a significantly higher level of collagen I,
resulting in an increased collagen I to III ratio [12].
Strengthened by our present findings, we speculate that
the common denominator is a change in collagen strength
originating from a genetic defect. Due to stretch and repair,
the disorder itself may then lead to an alteration in the local
collagen metabolism. Detailed assessment of changes on a
molecular level and the effects on collagen turn-over and
tensile strength in relation to POP is needed to unveil a
possible common molecular basis of collagen-associated
disorders arising in POP patients.
Although the large sample size is a clear strength of the
present study, we are aware of some limitations. We have
included index cases from two populations. Both provided
us with valuable information, but had their own limitations.
In one population, the index cases have undergone
gynaecological examination to assess for signs of POP
and completed a questionnaire on their own and family
members’ medical history. In these women, we were not
able to interview the family members directly. Their
medical information was obtained through the index cases,
which may lead to underreporting of the disorders. For
future research, a questionnaire or telephone interview
addressing all family members, might meet these objec-
tions. In the other population that we included in this study,
we were able to interview all individual female family
members, but we were limited by the fact that no
gynaecological examination was available in these women.
There is no known association between POP and the
presence of Fragile X syndrome or a premuation for this
syndrome. Therefore, we considered the risk to develop
POP to be equal for all women included in our study.
In the baseline characteristics, our control index cases
had a statistically significant higher number of children and
they were more likely to smoke or to have smoked in the
past, as compared to the POP index cases. The difference in
parity and smoking between both groups was not consid-
ered a confounder in this study, since the relation between
POP and collagen-associated disorders remained the same
after applying multivariate logistic regression.
In conclusion, our study shows that women with POP
are more likely to have first and second degree family
members with the same condition. POP index cases are
more likely to have a collagen-associated disorder. Further-
more, when assessing varicose veins, joint hypermobility
and rectal prolapse individually, these conditions are more
common amongst women with POP. A common aetiology
of these disorders, originating at the genetic level of
collagen, seems likely. In this study, however, this relation
was confined to POP patients.
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